Stribild 150 mg/1
elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate · TABLET, FILM COATED · Gilead Sciences, Inc.
Stribild is a tablet, film coated containing elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate at 150 mg/1, taken oral. Manufactured by Gilead Sciences, Inc..
Key Facts
- Brand Name
- Stribild
- Generic Name
- elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate
- NDC Code (Product)
61958-1201- Manufacturer
- Gilead Sciences, Inc.
- Strength
- 150 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA203100
- Drug Class
- Cytochrome P450 3A Inhibitor [EPC]; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC]
- Marketing Start
- 08/27/2012
Recall History
No Recall HistoryFrequently Asked Questions
What is Stribild used for?
Stribild contains elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Stribild a controlled substance?
Stribild is not classified as a controlled substance by the DEA.
What is the generic name for Stribild?
The generic name for Stribild is elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate. There are no other listed brand versions of elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate.
What is the NDC code for Stribild 150 mg/1?
The NDC (National Drug Code) for Stribild 150 mg/1 is 61958-1201, listed by Gilead Sciences, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)